Home > Insider Trading > Filing (0001209191-20-026529)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1661567	Michael Parini	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Adm, Leg & Bd Off	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-04-29	2,125	$90.29	28,963	No	4	M	Direct
Common Stock	Disposition	2020-04-29	145	$251.38	28,818	No	4	S	Direct
Common Stock	Disposition	2020-04-29	300	$252.70	28,518	No	4	S	Direct
Common Stock	Disposition	2020-04-29	400	$254.20	28,118	No	4	S	Direct
Common Stock	Disposition	2020-04-29	680	$255.44	27,438	No	4	S	Direct
Common Stock	Disposition	2020-04-29	500	$256.63	26,938	No	4	S	Direct
Common Stock	Disposition	2020-04-29	100	$258.15	26,838	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-04-29	2,125	$0.00	2,125	$90.29

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,125		2026-07-11	No	4	M	Direct

Footnotes

Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $251.38 (range $251.37 to $251.38).
Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $252.70 (range $252.48 to $252.96).
Open market sales reported on this line occurred at a weighted average price of $254.20 (range $253.60 to $254.55).
Open market sales reported on this line occurred at a weighted average price of $255.44 (range $255.03 to $255.97).
Open market sales reported on this line occurred at a weighted average price of $256.63 (range $256.35 to $256.96).
The option vests in 16 quarterly installments from 07/12/2016.